#162300

SiHa IFITM1+IFITM3 KO

Cat. #162300

SiHa IFITM1+IFITM3 KO

Cat. #: 162300

Organism: Human

Tissue: Uterus

Disease: Cancer

Model: Transgenic (KO)

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Marta Nekulová

Institute: Masaryk Memorial Cancer Institute

Tool Details
Target Details
Applications
Handling
Related Tools

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SiHa IFITM1+IFITM3 KO
  • Parental cell: SiHa
  • Organism: Human
  • Gender: Female
  • Tissue: Uterus
  • Donor: 55 years old, Japanese
  • Disease: Cancer
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Model: Transgenic (KO)
  • Model description: CRISPR Cas9 abolished expression of Interferon Induced Transmembrane Protein 1 (IFITM1) and Interferon Induced Transmembrane Protein 3 (IFITM3)
  • Crispr: Yes
  • Description: SiHa cell line with CRISPR Cas9 abolished expression of Interferon Induced Transmembrane Protein 1 (IFITM1) and 3 (IFITM3)
  • Application: Cell culture

Target Details

  • Target: Interferon Induced Transmembrane Protein 1 (IFITM1), Interferon-induced transmembrane protein 3 (IFITM3)
  • Target background: Interferon Induced Transmembrane Protein 1 (IFITM1) and Interferon-induced transmembrane protein 3 (IFITM3) are antiviral proteins which inhibit the entry of different viral components into the host cell cytoplasm. IFITM1 is also involved in the progression of laryngeal squamous carcinoma and in the distant metastasis of small-cell lung cancer. Interferon-induced transmembrane protein 3 (IFITM3) prevents the viral infection of the cell by modulating the local lipid

Applications

  • Application: Cell culture

Handling

  • Format: Frozen
  • Growth medium: RPMI 1640 medium supplemented with 10% (v/v) fetal bovine serum and 1% penicillin/streptomycin
  • Atmosphere: 5% CO2
  • Storage conditions: Liquid Nitrogen
  • Cultured in antibiotics: yes, 1% penicillin/streptomycin

Related Tools

  • Related tools: SiHa IFITM1 KO, SiHa IFITM3 KO